iTeos Therapeutics's total assets for Q2 2025 were $623.08M, a decrease of -5.43% from the previous quarter. ITOS total liabilities were $129.28M for the fiscal quarter, a 35.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.